Robocath designs and develops innovative robotic solutions for improving endovascular procedures. In particular, these procedures are carried out to treat vascular diseases, including heart attacks, the leading cause of death worldwide.
Currently in the approval stage, the first solution developed by Robocath (R-One) will be launched early 2019 in Europe and the Middle East.
Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies in emergency reception centers from expert centers, guaranteeing the best care pathway for all.
Selected by Forbes magazine as the fourth medical start-up in France, Robocath has around 20 employees.